Skip to main content
. 2021 May 3;12(6):1631–1659. doi: 10.1007/s13300-021-01060-8

Table 4.

Mortality due to CVD of patients with T2DM in Spain (2009–2019)

First author [citation number] of article (patient population analysed) Patients with T2DM (N) Follow-up period CVD CHD and MI CVA AAD ALLI PAD HF
National studies
 De Miguel-Yanes [27] 130,011 2002 13.04a 13.67a 14.97a 14.36a 5.53a
2006 12.41a 10.83 15.49a 12.52a 6.34a
2010 11.78a 9.49 a 14.94a 10.89a 6.04a
2014 10.77a 7.95a 14.27a 8.09a 5.47a
 López-de-Andrés [38] 19,232 2012–2013 (Abdominal) 9.37a
 López-de-Andrés [39] 155,676 2001–2010

M = 9.4a

W = 14.9

López-de-Andrés [40] 90,835 2001–2006

M = 10.1a

W = 15.9

 Mostaza [46] 498 1 year 5.6a
 Muñoz-Rivas [48] 553,775 2001–2015 8.35a
 Zapatero-Gaviria [66] 619,188 2015 6.8a
Regional studies
 Cano [21] (Catalonia) 2260 10 year 4.4a 1.8a 1.1a
 Formiga [31] (Catalonia, patients aged ≥ 75 years) 240 1 year 5.0a
 Mata-Cases [44] (Catalonia) 469 19.23b
 Piniés [56] (Basque Country) 65,651 1998–2000

M = 10.6b

W = 13.0

 Ramírez-Prado [57] (Valencia) 112 2010–2014 19.6a
 Salinero-Fort [60] (Madrid) 3443 2008–2012 13.7b

All data refer to in-hospital mortality, with the exception of data from Cano et al. [21] (Catalonia) and Salinero-Fort et al. [60] (Madrid)

W women, M men, MI myocardial infarction; for other abbreviations, see footnote Table 1

Data are shown as:

aPercentage (%)

bRate per 1000 patients/year